Most companies want to avoid FDA warning letters. To help medical device companies identify violations that might lead to a warning letter, this post will dive deeply into which specific types of violations are often found in warning letters that FDA issues.
Background
As you probably know, FDA has a formal process for evaluating inspection records and other materials to determine whether issuing a warning letter is appropriate. Those procedures can be found in chapter 4 of FDA’s Regulatory Procedures Manual. Section 4-1-10 of that chapter requires that warning letters include specific legal citations, in addition to plain English explanations of violations. The citations are supposed to make reference to both the statute and any applicable regulations.
As a consequence, to understand the content of the warning letters, we need to search for both statutory references as well as references to regulations. Because statutes are deliberately drafted to be broader in their language, references to the regulations tend to be more meaningful.
Blog Editors
Recent Updates
- Federal Embryo Adoption Program Raises Potential Legal Questions for Reproductive Health
- Vermont’s H. 583 Restricts Private Equity and Hedge Funds with Ownership and Controlling Interests from Interfering with Clinical Judgment of Health Care Providers
- DOJ’s Second National Health Care Fraud Takedown of the Second Trump Administration Heavily Targets Medicaid Fraud
- FDA Regulations to Establish Minimum CGMP Requirements for Manufacturing, Packaging, Labeling, and Holding of Dietary Supplements
- OIG Advisory Opinion 26-14 Offers Another Favorable Path for Patient Access Through Sponsored Testing